Coman, T., Morisset, S., Devillier, R., D'Aveni, M., Baron, F., Bay, J., Bazarbachi, A., Bilger, K., Bulabois, C., Castilla-Llorente, C., Ceballos, P., Chalandon, Y., Chantepie, S., Charbonnier, A., Chevallier, P., Contentin, N., Cornillon, J., Daguindau, E., Forcade, E., François, S., Guillerm, G., Labussière-Wallet, H., Lewalle, P., Loschi, M., Maertens, J., Maillard, N., Malard, F., Malfuson, J. V., Maury, S., Mear, J., Quoc, S. N., Poire, X., Rubio, M., Suarez, F., Turlure, P., Villate, A., Yakoub-Agha, I., Raus, N., Robin, M., Huynh, A., Michallet, M. (2025). Post-transplant cyclophosphamide (PTCy) versus other graft-versus-host disease prophylaxis strategies in reduced intensity allogeneic stem cell transplantation from related and matched unrelated donors in patients with acute myeloid leukemia and myelodysplastic syndromes: A study from the french society of bone marrow transplantation (SFGM-TC) registry. Blood. https://doi.org/10.1182/blood-2025-2450